Giammarco Surico

659 total citations
27 papers, 480 citations indexed

About

Giammarco Surico is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Giammarco Surico has authored 27 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in Giammarco Surico's work include Histiocytic Disorders and Treatments (4 papers), Vascular Malformations and Hemangiomas (4 papers) and Brain Metastases and Treatment (3 papers). Giammarco Surico is often cited by papers focused on Histiocytic Disorders and Treatments (4 papers), Vascular Malformations and Hemangiomas (4 papers) and Brain Metastases and Treatment (3 papers). Giammarco Surico collaborates with scholars based in Italy, Austria and Greece. Giammarco Surico's co-authors include N Rigillo, Doménico Ribatti, Angelo Vacca, Paola Muggeo, Antonio Pellegrino, Teresa Cirulli, Giulia Di Pietro, Roberto Ria, Angela Pennisi and Vito M. R. Muggeo and has published in prestigious journals such as Annals of Oncology, Life Sciences and European Journal of Cancer.

In The Last Decade

Giammarco Surico

26 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giammarco Surico Italy 11 191 118 99 97 94 27 480
Mirando Mršić Croatia 15 139 0.7× 135 1.1× 82 0.8× 171 1.8× 36 0.4× 41 562
Reiji Fukano Japan 15 159 0.8× 52 0.4× 87 0.9× 186 1.9× 37 0.4× 59 671
Eiichi Ishii Japan 11 65 0.3× 123 1.0× 70 0.7× 54 0.6× 116 1.2× 29 409
Ulrike Graubner Germany 14 140 0.7× 26 0.2× 148 1.5× 145 1.5× 77 0.8× 28 537
K.M. Kazemier Netherlands 13 261 1.4× 41 0.3× 303 3.1× 204 2.1× 36 0.4× 17 840
Joanna Osada Poland 15 171 0.9× 30 0.3× 68 0.7× 50 0.5× 100 1.1× 37 445
T. Fukuda Japan 14 84 0.4× 34 0.3× 133 1.3× 128 1.3× 101 1.1× 34 534
Hisashi Tsutsumi Japan 10 135 0.7× 40 0.3× 102 1.0× 100 1.0× 36 0.4× 28 488
Lars Munksgaard Denmark 11 212 1.1× 35 0.3× 34 0.3× 42 0.4× 38 0.4× 27 628
Grazia Bossi Italy 13 53 0.3× 91 0.8× 111 1.1× 80 0.8× 91 1.0× 42 486

Countries citing papers authored by Giammarco Surico

Since Specialization
Citations

This map shows the geographic impact of Giammarco Surico's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giammarco Surico with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giammarco Surico more than expected).

Fields of papers citing papers by Giammarco Surico

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giammarco Surico. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giammarco Surico. The network helps show where Giammarco Surico may publish in the future.

Co-authorship network of co-authors of Giammarco Surico

This figure shows the co-authorship network connecting the top 25 collaborators of Giammarco Surico. A scholar is included among the top collaborators of Giammarco Surico based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giammarco Surico. Giammarco Surico is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Surgo, Alessia, Roberta Carbonara, Isabella Bruno, et al.. (2024). Metabolic Complete Response of Metastatic Oncogene-Negative, PDL1-Negative Non-Small Cell Lung Cancer After Chemo-Immunotherapy and Radiotherapy: A Case Report. Current Oncology. 31(12). 8118–8126. 1 indexed citations
2.
Tebala, Giovanni Domenico, et al.. (2022). Oncological disease during the pandemic COVID-19: the solution is the "net". Minerva Medica. 113(2). 221–222.
3.
Laera, Letizia, Michele Ammendola, Nicola Silvestris, et al.. (2021). The Role of Laparoscopic Surgery in Localized Pancreatic Neuroendocrine Tumours. Current Treatment Options in Oncology. 22(4). 27–27. 4 indexed citations
4.
Pisconti, Salvatore, et al.. (2021). An Italian Model for the Management of Cancer Patients during COVID-19 Pandemic: The Regional Center for Oncological Orientation (COrO) of Taranto (ROP). Medical Principles and Practice. 31(1). 54–58. 1 indexed citations
5.
Gregucci, Fabiana, Alessia Surgo, Letizia Laera, et al.. (2021). Poor-Prognosis Patients Affected by Glioblastoma: Retrospective Study of Hypofractionated Radiotherapy with Simultaneous Integrated Boost and Concurrent/Adjuvant Temozolomide. Journal of Personalized Medicine. 11(11). 1145–1145. 16 indexed citations
6.
Cafiero, Concetta, Agnese Re, Gerardo D’Amato, et al.. (2020). <b><i>KRAS</i></b> and <b><i>BRAF</i></b> Concomitant Mutations in a Patient with Metastatic Colon Adenocarcinoma: An Interesting Case Report. Case Reports in Oncology. 13(2). 595–600. 4 indexed citations
7.
Fedele, Palma, et al.. (2018). An update on first line therapies for metastatic breast cancer. Expert Opinion on Pharmacotherapy. 19(3). 243–252. 9 indexed citations
8.
Migliorino, M.R., Alain Gelibter, Francesco Grossi, et al.. (2017). Use of nivolumab in elderly patients with advanced non-squamous NSCLC: Results from the Italian expanded access program (EAP). Annals of Oncology. 28. v471–v471. 6 indexed citations
9.
Cortesi, Enrico, Federico Cappuzzo, Luca Galli, et al.. (2017). Treatment beyond progression in patients with advanced RCC participating in the expanded access programme (EAP). Annals of Oncology. 28. v316–v316. 4 indexed citations
10.
Pellegrino, Antonio, Roberto Ria, Giulia Di Pietro, et al.. (2005). Bone marrow endothelial cells in multiple myeloma secrete CXC‐chemokines that mediate interactions with plasma cells. British Journal of Haematology. 129(2). 248–256. 81 indexed citations
11.
Burnelli, Roberta, Simone Cesaro, Maria Luisa Moleti, et al.. (2003). Results of the AIEOP NHL-92 protocol for the treatment of pediatric anaplastic large cell lymphomas. 9–9. 1 indexed citations
12.
Surico, Giammarco, et al.. (2001). Impairment of nasal mucociliary clearance after radiotherapy for childhood head cancer. Head & Neck. 23(6). 461–466. 24 indexed citations
13.
Ribatti, Doménico, Giammarco Surico, Angelo Vacca, et al.. (2001). Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with progression in human neuroblastoma. Life Sciences. 68(10). 1161–1168. 56 indexed citations
14.
Surico, Giammarco, Paola Muggeo, N Rigillo, & Helmut Gadner. (2000). Concurrent Langerhans cell histiocytosis and myelodysplasia in children. Medical and Pediatric Oncology. 35(4). 421–425. 1 indexed citations
15.
Surico, Giammarco, Paola Muggeo, Vito M. R. Muggeo, et al.. (2000). Ear involvement in childhood Langerhans' cell histiocytosis. Head & Neck. 22(1). 42–47. 23 indexed citations
16.
Surico, Giammarco, Paola Muggeo, N Rigillo, & Helmut Gadner. (2000). Concurrent Langerhans cell histiocytosis and myelodysplasia in children. Medical and Pediatric Oncology. 35(4). 421–425. 14 indexed citations
17.
Surico, Giammarco, et al.. (1999). Polyclonal hypergammaglobulinemia at the onset of acute myeloid leukemia in children. Annals of Hematology. 78(10). 445–448. 1 indexed citations
18.
Viscoli, Claudio, Elio Castagnola, M Giacchino, et al.. (1999). Bloodstream infections in children with cancer: a multicentre surveillance study of the Italian Association of Paediatric Haematology and Oncology. European Journal of Cancer. 35(5). 770–774. 83 indexed citations
19.
Ceci, Adriana, R. Colella, Giammarco Surico, et al.. (1993). Langerhans cell histiocytosis in childhood: Results from the Italian cooperative AIEOP‐CNR‐H.X '83 study. Medical and Pediatric Oncology. 21(4). 259–264. 74 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mirando Mršić Breakdown of academic impact, for papers by Reiji Fukano Breakdown of academic impact, for papers by Eiichi Ishii Breakdown of academic impact, for papers by Ulrike Graubner Breakdown of academic impact, for papers by K.M. Kazemier Breakdown of academic impact, for papers by Joanna Osada Breakdown of academic impact, for papers by T. Fukuda Breakdown of academic impact, for papers by Hisashi Tsutsumi Breakdown of academic impact, for papers by Lars Munksgaard Breakdown of academic impact, for papers by Grazia Bossi
Rankless by CCL
2026